Anti-TNF Therapy Slows Down AS Progression and Bone Loss, Study Says

Anti-TNF therapies can halt disease progression and bone loss, and are associated with clinical improvement in people with ankylosing spondylitis after one year of treatment, a study shows. The study, “Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in...